KIAA0146 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.233600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.706400E-01
Normal-vs-Stage2
6.126000E-01
Normal-vs-Stage3
1.580160E-01
Normal-vs-Stage4
9.659200E-01
Stage1-vs-Stage2
8.985200E-01
Stage1-vs-Stage3
1.652830E-01
Stage1-vs-Stage4
3.898600E-01
Stage2-vs-Stage3
1.783040E-01
Stage2-vs-Stage4
5.899000E-01
Stage3-vs-Stage4
1.309600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.663600E-01
Normal-vs-AfricanAmerican
2.480000E-01
Normal-vs-Asian
4.004000E-01
Caucasian-vs-AfricanAmerican
4.062200E-01
Caucasian-vs-Asian
2.883800E-01
AfricanAmerican-vs-Asian
9.852600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.443000E-01
Normal-vs-Female
6.118200E-01
Male-vs-Female
9.895200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.790600E-01
Normal-vs-Age(41-60Yrs)
8.688800E-01
Normal-vs-Age(61-80Yrs)
5.123800E-01
Normal-vs-Age(81-100Yrs)
7.348600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.380000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.282200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.327800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.852000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.019200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.025000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.931400E-01
Normal-vs-Daily Drinker
8.759400E-01
Normal-vs-Weekly Drinker
4.999000E-01
Normal-vs-Occasional Drinker
9.922200E-01
Normal-vs-Social Drinker
7.230200E-01
Non Drinker-vs-Daily Drinker
4.238400E-01
Non Drinker-vs-Weekly Drinker
8.409200E-01
Non Drinker-vs-Occasional Drinker
1.693580E-01
Non Drinker-vs-Social Drinker
7.781800E-01
Daily Drinker-vs-Weekly Drinker
4.566200E-01
Daily Drinker-vs-Occasional Drinker
7.265200E-01
Daily Drinker-vs-Social Drinker
7.228000E-01
Weekly Drinker-vs-Occasional Drinker
2.087800E-01
Weekly Drinker-vs-Social Drinker
7.219400E-01
Occasional Drinker-vs-Social Drinker
4.624800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.301800E-01
Normal-vs-Grade 2
5.642000E-02
Normal-vs-Grade 3
4.778400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.994200E-02
Grade 1-vs-Grade 3
4.132400E-02
Grade 1-vs-Grade 4
3.301800E-01
Grade 2-vs-Grade 3
5.797600E-01
Grade 2-vs-Grade 4
5.642000E-02
Grade 3-vs-Grade 4
4.778400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.419200E-01
Normal-vs-NonDiabetic
6.432800E-01
Diabetic-vs-NonDiabetic
8.888400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.459000E-01
Normal-vs-NoPancreatitis
5.973400E-01
Pancreatitis-vs-NoPancreatitis
2.204600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.635800E-01
Normal-vs-N1
5.882800E-01
N0-vs-N1
4.644800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.050800E-01
Normal-vs-TP53-NonMutant
4.675000E-01
TP53-Mutant-vs-TP53-NonMutant
5.498100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
